Daratumumab in Combination with Carfilzomib and Dexamethasone in Patients (pts) with Relapsed Multiple Myeloma (MMY1001): An Open-Label, Phase 1b Study. ASH - Lonial, S; San-Miguel, J; Martínez-Lopez, J (2017)
Abstract 1869